phenethyl isothiocyanate has been researched along with Osteogenic Sarcoma in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Li, J; Liu, J; Lv, H; Lyu, Y; Xie, L; Zhen, C | 1 |
Liu, JY; Lv, HH; Shang, P; Zhen, CX | 1 |
Liu, J; Lv, H; Shang, P; Zhen, C | 1 |
Fan, Q; Liu, C; Xiao, Z; Zhan, X | 1 |
Chou, ST; Chung, JG; Hsia, TC; Huang, AC; Ko, YC; Liao, CL; Lu, HF; Ma, CY; Wu, CL; Yang, JS | 1 |
5 other study(ies) available for phenethyl isothiocyanate and Osteogenic Sarcoma
Article | Year |
---|---|
Phenethyl isothiocyanate induces oxidative cell death in osteosarcoma cells with regulation on mitochondrial network, function and metabolism.
Topics: Apoptosis; Cell Death; Cell Line, Tumor; Humans; Isothiocyanates; Mitochondria; Osteosarcoma; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species | 2023 |
PEITC triggers multiple forms of cell death by GSH-iron-ROS regulation in K7M2 murine osteosarcoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Glutathione; Iron; Isothiocyanates; Male; MAP Kinase Signaling System; Mice, Inbred BALB C; Osteosarcoma; Reactive Oxygen Species | 2020 |
Topics: Animals; Cell Death; Humans; Iron; Isothiocyanates; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Osteosarcoma; Reactive Oxygen Species | 2020 |
Phenethyl isothiocyanate enhances adriamycin‑induced apoptosis in osteosarcoma cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Humans; Isothiocyanates; Osteosarcoma; Signal Transduction | 2015 |
Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase-3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic
Topics: Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; DNA Damage; Drug Evaluation, Preclinical; Enzyme Activation; Humans; Isothiocyanates; Membrane Potential, Mitochondrial; Nitric Oxide; Osteosarcoma; Reactive Oxygen Species; Signal Transduction | 2011 |